Literature DB >> 27201738

Health Technology Assessment, Price and Reimbursement Review for Orphan Drugs In France.

D Korchagina1, C Rémuzat1, J Rodrigues1, A Kornfeld2, M Toumi3.   

Abstract

Year:  2014        PMID： 27201738     DOI： 10.1016/j.jval.2014.08.1734

Source DB:  PubMed          Journal:  Value Health        ISSN： 1098-3015            Impact factor:   5.725


× No keyword cloud information.
  1 in total

Review 1.  HTA decision-making for drugs for rare diseases: comparison of processes across countries.

Authors:  Tania Stafinski; Judith Glennie; Andrea Young; Devidas Menon
Journal:  Orphanet J Rare Dis       Date:  2022-07-08       Impact factor: 4.303
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.